Pharmaceutical Manufacture At Russian Drugmaker OAO Pharmstandard

Pentalgin tablets sit after manufacture at OAO Pharmstandard's Leksredstva drug unit in Kursk, Russia, on Friday, Aug. 16, 2013. Pharmstandard said it will offer $590 million in cash and shares for Bever Pharmaceutical Pte. Ltd. in a deal that will give Pharmstandard board member Alexander Shuster an 18.7 percent stake in Russia's biggest drugmaker. Photographer: Andrey Rudakov/Bloomberg via Getty Images
Pentalgin tablets sit after manufacture at OAO Pharmstandard's Leksredstva drug unit in Kursk, Russia, on Friday, Aug. 16, 2013. Pharmstandard said it will offer $590 million in cash and shares for Bever Pharmaceutical Pte. Ltd. in a deal that will give Pharmstandard board member Alexander Shuster an 18.7 percent stake in Russia's biggest drugmaker. Photographer: Andrey Rudakov/Bloomberg via Getty Images
Pharmaceutical Manufacture At Russian Drugmaker OAO Pharmstandard
EINE LIZENZ KAUFEN
Wie darf ich dieses Bild verwenden?
Fr. 500.00
CHF

DETAILS

Einschränkungen:
Bei kommerzieller Verwendung sowie für verkaufsfördernde Zwecke kontaktieren Sie bitte Ihr lokales Büro.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Bildnachweis:
Bloomberg / Kontributor
Redaktionell #:
176919646
Kollektion:
Bloomberg
Erstellt am:
16. August 2013
Hochgeladen am:
Lizenztyp:
Lizenzpflichtig
Releaseangaben:
Kein Release verfügbar. Weitere Informationen
Quelle:
Bloomberg
Objektname:
RUSSIA PHARMA